The global Cancer Pain market was valued at US$ 6198 million in 2023 and is anticipated to reach US$ 8568 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.

Cancer Pain Market

Cancer pain is one of the most common symptoms in cancer patients. Pain can be caused by cancer, cancer treatment, or a combination of factors.

The growth of the global cancer pain market is mainly due to the increasing prevalence of cancer; rising geriatric population; rising healthcare expenditure; and increasing investment in research and development activities by various healthcare companies. Due to aging effects and genetic mutations, older people are more prone to various types of cancer, such as lung cancer, bladder cancer, kidney cancer, melanoma, etc. According to the National Cancer Institute, the median age at diagnosis is 61 for breast cancer, 68 for colorectal cancer, 70 for lung cancer and 66 for prostate cancer. However, side effects associated with drugs used in cancer pain treatment, such as drug tolerance, drug dependence, urinary retention, sleep disturbance, cognitive impairment, etc., are expected to restrain the growth of the cancer pain market over the forecast period.

This report aims to provide a comprehensive presentation of the global market for Cancer Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Pain.

Report Scope

The Cancer Pain market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cancer Pain market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Pain companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Cancer Pain Market Report

Report Metric	Details
Report Name	Cancer Pain Market
Accounted market size in 2023	US$ 6198 in million
Forecasted market size in 2030	US$ 8568 million
CAGR	5.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Opioids Non-Steroidal Anti-Inflammatory Drugs Others
Segment by Application	Radiotherapy Chemotherapy Hormone Therapy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals, Orexo, Sanofi, WEX Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Pain companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Cancer Pain Market growing?

Ans: The Cancer Pain Market witnessing a CAGR of 5.2% during the forecast period 2024-2030.

What is the Cancer Pain Market size in 2030?

Ans: The Cancer Pain Market size in 2030 will be US$ 8568 million.

Who are the main players in the Cancer Pain Market report?

Ans: The main players in the Cancer Pain Market are BioDelivery Science, ProStrakan Group, Teva pharmaceuticals, Eli-Lilly, Grunenthal Group, GW Pharmaceuticals, Johnson＆Johnson, Meda Pharmaceuticals, Orexo, Sanofi, WEX Pharmaceuticals

What are the Application segmentation covered in the Cancer Pain Market report?

Ans: The Applications covered in the Cancer Pain Market report are Radiotherapy, Chemotherapy, Hormone Therapy, Others

What are the Type segmentation covered in the Cancer Pain Market report?

Ans: The Types covered in the Cancer Pain Market report are Opioids, Non-Steroidal Anti-Inflammatory Drugs, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Pain Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Opioids

1.2.3 Non-Steroidal Anti-Inflammatory Drugs

1.2.4 Others

1.3 Market by Application

1.3.1 Global Cancer Pain Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Radiotherapy

1.3.3 Chemotherapy

1.3.4 Hormone Therapy

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cancer Pain Market Perspective (2019-2030)

2.2 Cancer Pain Growth Trends by Region

2.2.1 Global Cancer Pain Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Cancer Pain Historic Market Size by Region (2019-2024)

2.2.3 Cancer Pain Forecasted Market Size by Region (2025-2030)

2.3 Cancer Pain Market Dynamics

2.3.1 Cancer Pain Industry Trends

2.3.2 Cancer Pain Market Drivers

2.3.3 Cancer Pain Market Challenges

2.3.4 Cancer Pain Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cancer Pain Players by Revenue

3.1.1 Global Top Cancer Pain Players by Revenue (2019-2024)

3.1.2 Global Cancer Pain Revenue Market Share by Players (2019-2024)

3.2 Global Cancer Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Pain Revenue

3.4 Global Cancer Pain Market Concentration Ratio

3.4.1 Global Cancer Pain Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Pain Revenue in 2023

3.5 Cancer Pain Key Players Head office and Area Served

3.6 Key Players Cancer Pain Product Solution and Service

3.7 Date of Enter into Cancer Pain Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Pain Breakdown Data by Type

4.1 Global Cancer Pain Historic Market Size by Type (2019-2024)

4.2 Global Cancer Pain Forecasted Market Size by Type (2025-2030)

5 Cancer Pain Breakdown Data by Application

5.1 Global Cancer Pain Historic Market Size by Application (2019-2024)

5.2 Global Cancer Pain Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Cancer Pain Market Size (2019-2030)

6.2 North America Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Cancer Pain Market Size by Country (2019-2024)

6.4 North America Cancer Pain Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cancer Pain Market Size (2019-2030)

7.2 Europe Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Cancer Pain Market Size by Country (2019-2024)

7.4 Europe Cancer Pain Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Cancer Pain Market Size (2019-2030)

8.2 Asia-Pacific Cancer Pain Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Cancer Pain Market Size by Region (2019-2024)

8.4 Asia-Pacific Cancer Pain Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Cancer Pain Market Size (2019-2030)

9.2 Latin America Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Cancer Pain Market Size by Country (2019-2024)

9.4 Latin America Cancer Pain Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cancer Pain Market Size (2019-2030)

10.2 Middle East & Africa Cancer Pain Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Cancer Pain Market Size by Country (2019-2024)

10.4 Middle East & Africa Cancer Pain Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 BioDelivery Science

11.1.1 BioDelivery Science Company Detail

11.1.2 BioDelivery Science Business Overview

11.1.3 BioDelivery Science Cancer Pain Introduction

11.1.4 BioDelivery Science Revenue in Cancer Pain Business (2019-2024)

11.1.5 BioDelivery Science Recent Development

11.2 ProStrakan Group

11.2.1 ProStrakan Group Company Detail

11.2.2 ProStrakan Group Business Overview

11.2.3 ProStrakan Group Cancer Pain Introduction

11.2.4 ProStrakan Group Revenue in Cancer Pain Business (2019-2024)

11.2.5 ProStrakan Group Recent Development

11.3 Teva pharmaceuticals

11.3.1 Teva pharmaceuticals Company Detail

11.3.2 Teva pharmaceuticals Business Overview

11.3.3 Teva pharmaceuticals Cancer Pain Introduction

11.3.4 Teva pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.3.5 Teva pharmaceuticals Recent Development

11.4 Eli-Lilly

11.4.1 Eli-Lilly Company Detail

11.4.2 Eli-Lilly Business Overview

11.4.3 Eli-Lilly Cancer Pain Introduction

11.4.4 Eli-Lilly Revenue in Cancer Pain Business (2019-2024)

11.4.5 Eli-Lilly Recent Development

11.5 Grunenthal Group

11.5.1 Grunenthal Group Company Detail

11.5.2 Grunenthal Group Business Overview

11.5.3 Grunenthal Group Cancer Pain Introduction

11.5.4 Grunenthal Group Revenue in Cancer Pain Business (2019-2024)

11.5.5 Grunenthal Group Recent Development

11.6 GW Pharmaceuticals

11.6.1 GW Pharmaceuticals Company Detail

11.6.2 GW Pharmaceuticals Business Overview

11.6.3 GW Pharmaceuticals Cancer Pain Introduction

11.6.4 GW Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.6.5 GW Pharmaceuticals Recent Development

11.7 Johnson＆Johnson

11.7.1 Johnson＆Johnson Company Detail

11.7.2 Johnson＆Johnson Business Overview

11.7.3 Johnson＆Johnson Cancer Pain Introduction

11.7.4 Johnson＆Johnson Revenue in Cancer Pain Business (2019-2024)

11.7.5 Johnson＆Johnson Recent Development

11.8 Meda Pharmaceuticals

11.8.1 Meda Pharmaceuticals Company Detail

11.8.2 Meda Pharmaceuticals Business Overview

11.8.3 Meda Pharmaceuticals Cancer Pain Introduction

11.8.4 Meda Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.8.5 Meda Pharmaceuticals Recent Development

11.9 Orexo

11.9.1 Orexo Company Detail

11.9.2 Orexo Business Overview

11.9.3 Orexo Cancer Pain Introduction

11.9.4 Orexo Revenue in Cancer Pain Business (2019-2024)

11.9.5 Orexo Recent Development

11.10 Sanofi

11.10.1 Sanofi Company Detail

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Cancer Pain Introduction

11.10.4 Sanofi Revenue in Cancer Pain Business (2019-2024)

11.10.5 Sanofi Recent Development

11.11 WEX Pharmaceuticals

11.11.1 WEX Pharmaceuticals Company Detail

11.11.2 WEX Pharmaceuticals Business Overview

11.11.3 WEX Pharmaceuticals Cancer Pain Introduction

11.11.4 WEX Pharmaceuticals Revenue in Cancer Pain Business (2019-2024)

11.11.5 WEX Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Cancer Pain Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Opioids

Table 3. Key Players of Non-Steroidal Anti-Inflammatory Drugs

Table 4. Key Players of Others

Table 5. Global Cancer Pain Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Cancer Pain Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Cancer Pain Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Cancer Pain Market Share by Region (2019-2024)

Table 9. Global Cancer Pain Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Cancer Pain Market Share by Region (2025-2030)

Table 11. Cancer Pain Market Trends

Table 12. Cancer Pain Market Drivers

Table 13. Cancer Pain Market Challenges

Table 14. Cancer Pain Market Restraints

Table 15. Global Cancer Pain Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Cancer Pain Market Share by Players (2019-2024)

Table 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2023)

Table 18. Ranking of Global Top Cancer Pain Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Cancer Pain Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Cancer Pain Product Solution and Service

Table 22. Date of Enter into Cancer Pain Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Cancer Pain Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Cancer Pain Revenue Market Share by Type (2019-2024)

Table 26. Global Cancer Pain Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Cancer Pain Revenue Market Share by Type (2025-2030)

Table 28. Global Cancer Pain Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Cancer Pain Revenue Market Share by Application (2019-2024)

Table 30. Global Cancer Pain Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Cancer Pain Revenue Market Share by Application (2025-2030)

Table 32. North America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Cancer Pain Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Cancer Pain Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Cancer Pain Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Cancer Pain Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Cancer Pain Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Cancer Pain Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Cancer Pain Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Cancer Pain Market Size by Country (2025-2030) & (US$ Million)

Table 47. BioDelivery Science Company Detail

Table 48. BioDelivery Science Business Overview

Table 49. BioDelivery Science Cancer Pain Product

Table 50. BioDelivery Science Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 51. BioDelivery Science Recent Development

Table 52. ProStrakan Group Company Detail

Table 53. ProStrakan Group Business Overview

Table 54. ProStrakan Group Cancer Pain Product

Table 55. ProStrakan Group Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 56. ProStrakan Group Recent Development

Table 57. Teva pharmaceuticals Company Detail

Table 58. Teva pharmaceuticals Business Overview

Table 59. Teva pharmaceuticals Cancer Pain Product

Table 60. Teva pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 61. Teva pharmaceuticals Recent Development

Table 62. Eli-Lilly Company Detail

Table 63. Eli-Lilly Business Overview

Table 64. Eli-Lilly Cancer Pain Product

Table 65. Eli-Lilly Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 66. Eli-Lilly Recent Development

Table 67. Grunenthal Group Company Detail

Table 68. Grunenthal Group Business Overview

Table 69. Grunenthal Group Cancer Pain Product

Table 70. Grunenthal Group Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 71. Grunenthal Group Recent Development

Table 72. GW Pharmaceuticals Company Detail

Table 73. GW Pharmaceuticals Business Overview

Table 74. GW Pharmaceuticals Cancer Pain Product

Table 75. GW Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 76. GW Pharmaceuticals Recent Development

Table 77. Johnson＆Johnson Company Detail

Table 78. Johnson＆Johnson Business Overview

Table 79. Johnson＆Johnson Cancer Pain Product

Table 80. Johnson＆Johnson Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 81. Johnson＆Johnson Recent Development

Table 82. Meda Pharmaceuticals Company Detail

Table 83. Meda Pharmaceuticals Business Overview

Table 84. Meda Pharmaceuticals Cancer Pain Product

Table 85. Meda Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 86. Meda Pharmaceuticals Recent Development

Table 87. Orexo Company Detail

Table 88. Orexo Business Overview

Table 89. Orexo Cancer Pain Product

Table 90. Orexo Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 91. Orexo Recent Development

Table 92. Sanofi Company Detail

Table 93. Sanofi Business Overview

Table 94. Sanofi Cancer Pain Product

Table 95. Sanofi Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 96. Sanofi Recent Development

Table 97. WEX Pharmaceuticals Company Detail

Table 98. WEX Pharmaceuticals Business Overview

Table 99. WEX Pharmaceuticals Cancer Pain Product

Table 100. WEX Pharmaceuticals Revenue in Cancer Pain Business (2019-2024) & (US$ Million)

Table 101. WEX Pharmaceuticals Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Cancer Pain Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Cancer Pain Market Share by Type: 2023 VS 2030

Figure 3. Opioids Features

Figure 4. Non-Steroidal Anti-Inflammatory Drugs Features

Figure 5. Others Features

Figure 6. Global Cancer Pain Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Cancer Pain Market Share by Application: 2023 VS 2030

Figure 8. Radiotherapy Case Studies

Figure 9. Chemotherapy Case Studies

Figure 10. Hormone Therapy Case Studies

Figure 11. Others Case Studies

Figure 12. Cancer Pain Report Years Considered

Figure 13. Global Cancer Pain Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Cancer Pain Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Cancer Pain Market Share by Region: 2023 VS 2030

Figure 16. Global Cancer Pain Market Share by Players in 2023

Figure 17. Global Top Cancer Pain Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Pain as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Cancer Pain Revenue in 2023

Figure 19. North America Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Cancer Pain Market Share by Country (2019-2030)

Figure 21. United States Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Cancer Pain Market Share by Country (2019-2030)

Figure 25. Germany Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Cancer Pain Market Share by Region (2019-2030)

Figure 33. China Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Cancer Pain Market Share by Country (2019-2030)

Figure 41. Mexico Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Cancer Pain Market Share by Country (2019-2030)

Figure 45. Turkey Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Cancer Pain Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. BioDelivery Science Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 48. ProStrakan Group Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 49. Teva pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 50. Eli-Lilly Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 51. Grunenthal Group Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 52. GW Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 53. Johnson＆Johnson Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 54. Meda Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 55. Orexo Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 56. Sanofi Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 57. WEX Pharmaceuticals Revenue Growth Rate in Cancer Pain Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Colon Cancer Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-31C5944

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global CAR T-Cell Immunotherapy Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-10J13802

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Color Detection Sensors Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-6G9623

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Appendix Cancer Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-2H1312

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions